Ignite Creation Date:
2025-12-24 @ 9:20 PM
Ignite Modification Date:
2026-02-08 @ 9:42 AM
Study NCT ID:
NCT01798004
Status:
COMPLETED
Last Update Posted:
2024-07-15
First Post:
2013-01-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Sponsor:
Children's Oncology Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-04-09
Start Date Type:
ACTUAL
Primary Completion Date:
2015-07-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-06-30
Completion Date Type:
ACTUAL
First Submit Date:
2013-01-06
First Submit QC Date:
None
Study First Post Date:
2013-02-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-12-19
Results First Submit QC Date:
None
Results First Post Date:
2017-02-09
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-03
Last Update Post Date:
2024-07-15
Last Update Post Date Type:
ACTUAL